Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Silvadene — SSD
Application NDA018578 (NDA)
Silvadene — SILVADENE
Application NDA017381 (NDA)
Silvadene — THERMAZENE
Application NDA018810 (NDA)
Silvadene — SILDAFLO
Application NDA019608 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)